NCT00283699 - A Pilot Study of Neurocysticercosis Treatment | Biotech Hunter

Enrollment

178

Participants

Timeline

Start Date

February 28, 2001

Primary Completion Date

February 28, 2005

Study Completion Date

February 28, 2005

Conditions

Neurocysticercosis

Interventions

DRUG

albendazole

Active drug or placebo dosed bid p o for 8days

OTHER

placebo

an inactive substance

Trial Locations (5)

Unknown

Vicente Corral Moscoso Hospital of Cuenca, Centro de Epilepsia, Facultad de Ciencias Médicinas de la Universidad de Cuenca IDIUC (Área 5), Av. 12 de Abril. Cdla., Cuenca

Teodoro Maldonado Carbo Hospital, Av. 25 de Julio Vía Puerto Marítimo, Guayaquil

Baca Ortiz Children's Hospital, Av. Colon s/n y 6 de Diciembre, Quito

Hospital Carlos Andrade Marin, Av. 10 de agosto y Bogotá, Quito

Hospital Eugenio Espejo, Servicio de Neurología, Av. Colombia s/n, Quito

All Listed Sponsors

collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

lead

Columbia University

OTHER